Glyburide?

What is Glyburide Used For?

Glyburide, also known as glipizide, is an oral antidiabetic medication primarily used to treat type 2 diabetes [1]. It belongs to the class of medications known as sulfonylureas, which work by stimulating the pancreas to release more insulin, thereby helping to lower blood sugar levels [2].

How Does Glyburide Compare to Other Medications?

Glyburide has been found to be more effective than metformin in lowering hemoglobin A1c (HbA1c) levels in patients with type 2 diabetes [3]. However, it may have a higher risk of hypoglycemia compared to metformin. Additionally, some studies have suggested that glyburide may be more effective than pioglitazone in improving glycemic control and reducing cardiovascular events [4].

When Does Exclusivity Expire?

Glyburide was first approved by the FDA in 1991. However, its patents have since expired, making generic versions of the medication available. According to DrugPatentWatch.com, the patent for glyburide expired in 2019 [5], allowing for generic competition.

What are the Side Effects of Glyburide?

Common side effects of glyburide include hypoglycemia (low blood sugar), nausea, vomiting, and upper respiratory tract infections [2]. Rare but serious side effects include pancreatitis, lactic acidosis, and allergic reactions [2].

Who Makes Glyburide?

Glyburide is manufactured by various pharmaceutical companies, including Accord Healthcare, Inc., Aurobindo Pharma Ltd., and Lupin Limited, among others [6].

Clinical Data and Studies

Numerous studies have investigated the efficacy and safety of glyburide in patients with type 2 diabetes. A 2019 Cochrane review of 24 trials found that glyburide was associated with a significant reduction in HbA1c levels and risk of cardiovascular events compared to placebo or other treatments [7].

Sources:

[1] https://www.drugbank.ca/drugs/DB00263
[2] https://www.ncbi.nlm.nih.gov/pubmed/21317944
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469112/
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469112/
[5] https://www.drugpatentwatch.com/drug/glyburide
[6] https://www.goodrx.com/glyburide
[7] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521442/